Immunovant
Lauren Schrier, M.B.A., is Vice President of Marketing at Immunovant. Prior to joining Immunovant, Lauren spent nearly 8 years at Celgene, where she held leadership roles including Project Leader of Otezla Dermatology and Chief of Staff of the Inflammation and Immunology franchise. While in Global Marketing and Commercial Development, Lauren was responsible for new product planning initiatives supporting the global commercialization of Otezla, franchise business development and portfolio strategies.
Prior to Celgene, Lauren worked in management consulting at Accenture and Easton Associates, where she advised biopharma and medtech companies in market assessment and strategy development engagements.
Lauren earned a B.S.E. in Chemical Engineering from the University of Pennsylvania, and an M.B.A. in Healthcare and Pharmaceutical Management from Columbia Business School.
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.